Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
The Captial Market (CapitalMarket.com) rating for Nureca IPO is 32. Their analysis recommends Do Not Subscribe for the IPO.
| Reviewer | Rating Score | Rating |
|---|---|---|
| Capital Market | 32 | Do Not Subscribe |
[Dilip Davda] Though IPO appears lucratively priced based on its super performance for FY21 H1, the sustainability of it raises concern. The company is in a highly competitive and fragmented segment. Its own plant which is on lease may face family dispute risk. Considering these aspects, cash surplus risk savvy investors may consider investment at their own risk. Read detail review...
Nureca IPO Reviews, analysis and views by popular members. Read Nureca Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
RHP